
Cantor Fitzgerald Initiates Coverage on Prenetics with “Overweight” Rating
HONG KONG, Jan 26, 2023 – (ACN Newswire via SEAPRWire.com) – It is reported that Cantor Fitzgerald initiated coverage on Prenetics Global (PRE.US) with “Overweight” rating and target price at USD7.00. Cantor Fitzgerald holds a favorable view of the consumer and clinical testing markets, with Prenetics’ focus on diagnostic and preventive testing coupled with personalized... » read more